Bone mineral density testing: too much of a good thing?
作者信息
Korownyk Christina, Allan G Michael, Kolber Michael R
出版信息
Can Fam Physician. 2010 Dec;56(12):1299.
Abstract
摘要
相似文献
1
Bone mineral density testing: too much of a good thing?骨密度检测：好事过头了？
Can Fam Physician. 2010 Dec;56(12):1299.
2
[Measurement of bone mineral density is unnecessary for monitoring of bisphosphonate treatment].监测双膦酸盐治疗时无需测量骨密度。
Clin Calcium. 2011 Jan;21(1):120-3.
3
Clinical practice. Osteoporosis in men.临床实践。男性骨质疏松症
N Engl J Med. 2008 Apr 3;358(14):1474-82. doi: 10.1056/NEJMcp0707217.
4
[Prevention and treatment of osteoporosis].[骨质疏松症的预防与治疗]
Nihon Ronen Igakkai Zasshi. 2007 May;44(3):299-301. doi: 10.3143/geriatrics.44.299.
5
[Diagnosis and treatment of osteoporosis in men].男性骨质疏松症的诊断与治疗
Nihon Rinsho. 2007 Nov 28;65 Suppl 9:495-8.
6
[Practical guidelines for the management of osteoporosis--evidence-based and cost-effective].骨质疏松症管理实用指南——基于证据且具有成本效益
Dtsch Med Wochenschr. 2007 May 4;132(18):995-9. doi: 10.1055/s-2007-979369.
7
Osteoporosis Management.骨质疏松症管理
J Womens Health (Larchmt). 2017 Aug;26(8):918-921. doi: 10.1089/jwh.2017.6496. Epub 2017 Jul 7.
8
[Image assessment of the treatment effect on osteoporosis: bisphosphonates].骨质疏松症治疗效果的影像学评估：双膦酸盐类药物
Clin Calcium. 2011 Jul;21(7):1041-6.
9
Postmenopausal osteoporosis: another approach to management.绝经后骨质疏松症：另一种管理方法。
J Fam Pract. 2010 Jun;59(6):E1-7.
10
[Advances in the field of osteoporosis].[骨质疏松领域的进展]
Rev Prat. 2007 Oct 15;57(15):1629-31.
引用本文的文献
1
Understanding Referral Patterns for Bone Mineral Density Testing among Family Physicians: A Qualitative Descriptive Study.了解家庭医生中骨密度检测的转诊模式：一项定性描述性研究。
J Osteoporos. 2016;2016:2937426. doi: 10.1155/2016/2937426. Epub 2016 Jan 19.
本文引用的文献
1
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary.《2010年加拿大骨质疏松症诊断与管理临床实践指南：摘要》
CMAJ. 2010 Nov 23;182(17):1864-73. doi: 10.1503/cmaj.100771. Epub 2010 Oct 12.
2
Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool.基于 BMD 和临床危险因素预测绝经早期妇女骨折风险：WHO FRAX 工具的敏感性。
J Bone Miner Res. 2010 May;25(5):1002-9. doi: 10.1002/jbmr.12.
3
A comparison of prediction models for fractures in older women: is more better?老年女性骨折预测模型的比较：越多越好吗？
Arch Intern Med. 2009 Dec 14;169(22):2087-94. doi: 10.1001/archinternmed.2009.404.
4
Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data.开始双膦酸盐治疗后进行骨密度常规监测的价值：试验数据的二次分析
BMJ. 2009 Jun 23;338:b2266. doi: 10.1136/bmj.b2266.
5
Risk of fracture among women who lose bone density during treatment with alendronate. The Fracture Intervention Trial.在接受阿仑膦酸盐治疗期间骨密度降低的女性中的骨折风险。骨折干预试验。
Osteoporos Int. 2005 Jul;16(7):842-8. doi: 10.1007/s00198-004-1770-7. Epub 2004 Dec 3.
6
2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.2002年加拿大骨质疏松症诊断与管理临床实践指南。
CMAJ. 2002 Nov 12;167(10 Suppl):S1-34.
7
Quality control of bone densitometry in a national health survey (NHANES III) using three mobile examination centers.
J Bone Miner Res. 1994 Jun;9(6):951-60. doi: 10.1002/jbmr.5650090621.
8
Comparative performance in vitro and in vivo of Lunar DPX and Hologic QDR-1000 dual energy X-ray absorptiometers.
Br J Radiol. 1991 Nov;64(767):1023-9. doi: 10.1259/0007-1285-64-767-1023.
Zotero 插件